Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2803-2809
Published online before print June 12, 2006, doi: 10.1161/CIRCULATIONAHA.106.618066
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
113/24/2803    most recent
CIRCULATIONAHA.106.618066v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spertus, J. A.
Right arrow Articles by Cohen, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spertus, J. A.
Right arrow Articles by Cohen, D. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Health policy and outcome research
Right arrow Acute myocardial infarction
Right arrow Catheter-based coronary interventions: stents
Right arrow Restenosis
Right arrow Other Treatment

(Circulation. 2006;113:2803-2809.)
© 2006 American Heart Association, Inc.


Coronary Heart Disease

Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement

Results From the PREMIER Registry

John A. Spertus, MD, MPH; Richard Kettelkamp, DO; Clifton Vance, MD; Carole Decker, RN, PhD; Philip G. Jones, MS; John S. Rumsfeld, MD, PhD; John C. Messenger, MD; Sanjaya Khanal, MD; Eric D. Peterson, MD, MPH; Richard G. Bach, MD; Harlan M. Krumholz, MD, SM; David J. Cohen, MD, MSc

From the Mid America Heart Institute and the University of Missouri at Kansas City (J.A.S., R.K., C.V., C.D., P.G.J.); the University of Colorado Hospital/Denver VA Medical Center (J.S.R.), Denver, Colo; the University of Colorado Health Sciences Center (J.C.M.), Denver; the Henry Ford Health System (S.K.), Detroit, Mich; Duke University (E.D.P.), Durham, NC; Barnes-Jewish Hospital and Washington University School of Medicine (R.G.B.), St. Louis, Mo; Yale University (H.M.K.), New Haven, Conn; and Beth Israel–Deaconess Medical Center (D.J.C.), Boston, Mass.

Correspondence to John Spertus, MD, MPH, Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO 64111. E-mail spertusj{at}umkc.edu

Received February 1, 2006; revision received April 11, 2006; accepted April 20, 2006.

Background— Although drug-eluting stents (DES) significantly reduce restenosis, they require 3 to 6 months of thienopyridine therapy to prevent stent thrombosis. The rate and consequences of prematurely discontinuing thienopyridine therapy after DES placement for acute myocardial infarction (MI) are unknown.

Methods and Results— We used prospectively collected data from a 19-center study of MI patients to examine the prevalence and predictors of thienopyridine discontinuation 30 days after DES treatment. We then compared the mortality and cardiac hospitalization rates for the next 11 months between those who stopped and those who continued thienopyridine therapy. Among 500 DES-treated MI patients who were discharged on thienopyridine therapy, 68 (13.6%) stopped therapy within 30 days. Those who stopped were older, less likely to have completed high school or be married, more likely to avoid health care because of cost, and more likely to have had preexisting cardiovascular disease or anemia at presentation. They were also less likely to have received discharge instructions about their medications or a cardiac rehabilitation referral. Patients who stopped thienopyridine therapy by 30 days were more likely to die during the next 11 months (7.5% versus 0.7%, P<0.0001; adjusted hazard ratio=9.0; 95% confidence interval=1.3 to 60.6) and to be rehospitalized (23% versus 14%, P=0.08; adjusted hazard ratio=1.5; 95% confidence interval=0.78 to 3.0).

Conclusions— Almost 1 in 7 MI patients who received a DES were no longer taking thienopyridines by 30 days. Prematurely stopping thienopyridine therapy was strongly associated with subsequent mortality. Strategies to improve the use of thienopyridines are needed to optimize the outcomes of MI patients treated with DES.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Eur Heart J SupplHome page
L. Wallentin
Dual antiplatelet therapy in the drug-eluting stent era
Eur. Heart J. Suppl., May 1, 2008; 10(suppl_D): D38 - D44.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. Valgimigli, G. Campo, G. Percoco, L. Bolognese, C. Vassanelli, S. Colangelo, N. de Cesare, A. E. Rodriguez, M. Ferrario, R. Moreno, et al.
Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction: The MULTISTRATEGY Randomized Trial
JAMA, April 16, 2008; 299(15): 1788 - 1799.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. J. Price, S. Endemann, R. R. Gollapudi, R. Valencia, C. T. Stinis, J. P. Levisay, A. Ernst, N. S. Sawhney, R. A. Schatz, and P. S. Teirstein
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
Eur. Heart J., April 2, 2008; 29(8): 992 - 1000.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. R. Holmes Jr
Resistance to what, does it matter? How do we study it?
Eur. Heart J., April 2, 2008; 29(8): 957 - 958.
[Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
C. L. Grines, J. A. Goldstein, and R. D. Safian
Should We Routinely Use Drug-Eluting Stents for Acute Myocardial Infarction?: Let's Wait and See
J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 136 - 138.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
S. L. Daugherty, P. M. Ho, J. A. Spertus, P. G. Jones, R. G. Bach, H. M. Krumholz, E. D. Peterson, J. S. Rumsfeld, and F. A. Masoudi
Association of Early Follow-up After Acute Myocardial Infarction With Higher Rates of Medication Use
Arch Intern Med, March 10, 2008; 168(5): 485 - 491.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. A. Jackevicius, P. Li, and J. V. Tu
Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial Infarction
Circulation, February 26, 2008; 117(8): 1028 - 1036.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
O. Sheehy MSc, J. LeLorier MD PhD, and S. Rinfret MD MSc
Restrictive access to clopidogrel and mortality following coronary stent implantation
Can. Med. Assoc. J., February 12, 2008; 178(4): 413 - 420.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. Jeremias and A. Kirtane
Balancing Efficacy and Safety of Drug-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
Ann Intern Med, February 5, 2008; 148(3): 234 - 238.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D. Austin, J. P Pell, and K. G Oldroyd
Drug-eluting stents: do the risks really outweigh the benefits?
Heart, February 1, 2008; 94(2): 127 - 128.
[Full Text] [PDF]


Home page
QJMHome page
P. Foley, S. Foley, T. Kinnaird, and R.A. Anderson
Clinical review: gastrointestinal bleeding after percutaneous coronary intervention: a deadly combination
QJM, January 21, 2008; (2008) hcm112v1.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
American College of Cardiology/American Heart Asso, 2007 Writing Group to Review New Evidence and Upda, S. B. King III, S. C. Smith Jr, J. W. Hirshfeld Jr, A. K. Jacobs, D. A. Morrison, and D. O. Williams
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
J. Am. Coll. Cardiol., January 15, 2008; 51(2): 172 - 209.
[Full Text] [PDF]


Home page
CirculationHome page
S. B. King III, S. C. Smith Jr, J. W. Hirshfeld Jr, A. K. Jacobs, D. A. Morrison, D. O. Williams, 2005 WRITING COMMITTEE MEMBERS, S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, et al.
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee
Circulation, January 15, 2008; 117(2): 261 - 295.
[Full Text] [PDF]


Home page
Card Surg AdultHome page
R. F. Padera Jr. and F. J. Schoen
Pathology of Cardiac Surgery
Card. Surg. Adult, January 1, 2008; 3(2008): 111 - 178.
[Full Text]


Home page
Eur Heart J SupplHome page
A. K. Gitt and A. Betriu
Antiplatelet therapy in acute coronary syndromes
Eur. Heart J. Suppl., January 1, 2008; 10(suppl_A): A4 - A12.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. M. Krumholz and F. A. Masoudi
The Year in Epidemiology, Health Services Research, and Outcomes Research
J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2254 - 2262.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. F. von Tiehl, M. J. Price, R. Valencia, K. J. Ludington, P. S. Teirstein, and R. A. Simon
Clopidogrel Desensitization After Drug-Eluting Stent Placement
J. Am. Coll. Cardiol., November 20, 2007; 50(21): 2039 - 2043.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
U. Zeymer and R. Zahn
Drug-eluting stents: effective and safe for every patient and every lesion?
Eur. Heart J., November 1, 2007; 28(21): 2559 - 2560.
[Full Text] [PDF]


Home page
CirculationHome page
S. Windecker and B. Meier
Late Coronary Stent Thrombosis
Circulation, October 23, 2007; 116(17): 1952 - 1965.
[Full Text] [PDF]


Home page
CirculationHome page
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al.
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)
Circulation, October 23, 2007; 116(17): e418 - e499.
[Full Text] [PDF]


Home page
NEJMHome page
J. V. Tu, J. Bowen, M. Chiu, D. T. Ko, P. C. Austin, Y. He, R. Hopkins, J.-E. Tarride, G. Blackhouse, C. Lazzam, et al.
Effectiveness and Safety of Drug-Eluting Stents in Ontario
N. Engl. J. Med., October 4, 2007; 357(14): 1393 - 1402.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Colombo and A. Chieffo
Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Unsettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease)
Circulation, September 18, 2007; 116(12): 1424 - 1432.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. E. Rodriguez, A. O. Maree, J. Mieres, D. Berrocal, L. Grinfeld, C. Fernandez-Pereira, V. Curotto, A. Rodriguez-Granillo, W. O'Neill, and I. F. Palacios
Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry
Eur. Heart J., September 1, 2007; 28(17): 2118 - 2125.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
P.-G. Chassot, A. Delabays, and D. R. Spahn
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction
Br. J. Anaesth., September 1, 2007; 99(3): 316 - 328.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Daemen and P. W. Serruys
Drug-Eluting Stent Update 2007: Part II: Unsettled Issues
Circulation, August 21, 2007; 116(8): 961 - 968.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157.
[Full Text] [PDF]


Home page
CirculationHome page
A. A. Bavry and D. L. Bhatt
Drug-Eluting Stents: Dual Antiplatelet Therapy for Every Survivor?
Circulation, August 14, 2007; 116(7): 696 - 699.
[Full Text] [PDF]


Home page
CirculationHome page
F. Airoldi, A. Colombo, N. Morici, A. Latib, J. Cosgrave, L. Buellesfeld, E. Bonizzoni, M. Carlino, U. Gerckens, C. Godino, et al.
Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment
Circulation, August 14, 2007; 116(7): 745 - 754.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. L. Frye
Update in Cardiology
Ann Intern Med, August 7, 2007; 147(3): 180 - 186.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol., July 17, 2007; 50(3): 270 - 285.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Kaul, P. K. Shah, and G. A. Diamond
As Time Goes By: Current Status and Future Directions in the Controversy Over Stenting
J. Am. Coll. Cardiol., July 10, 2007; 50(2): 128 - 137.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Jaffe and B. H. Strauss
Late and Very Late Thrombosis of Drug-Eluting Stents: Evolving Concepts and Perspectives
J. Am. Coll. Cardiol., July 10, 2007; 50(2): 119 - 127.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. R. Holmes Jr, D. J. Kereiakes, W. K. Laskey, A. Colombo, S. G. Ellis, T. D. Henry, J. J. Popma, P. W.J.C. Serruys, T. Kimura, D. O. Williams, et al.
Thrombosis and Drug-Eluting Stents: An Objective Appraisal
J. Am. Coll. Cardiol., July 10, 2007; 50(2): 109 - 118.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
S. A. Spinler and R. L. Wilensky
Duration of clopidogrel therapy after placement of drug-eluting intracoronary stent
Am. J. Health Syst. Pharm., July 1, 2007; 64(13): 1432 - 1434.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. T. Dove, D. J. Moliterno, W. D. Weaver, and M. E. Shelton
President's Page: Drug-Eluting Stents in Contemporary Practice--A Call for a Real-World, Open-Entry, Device-Tracking Registry
J. Am. Coll. Cardiol., June 5, 2007; 49(22): 2223 - 2226.
[Full Text] [PDF]


Home page
JAMAHome page
H. K. Win, A. E. Caldera, K. Maresh, J. Lopez, C. S. Rihal, M. A. Parikh, J. F. Granada, S. Marulkar, D. Nassif, D. J. Cohen, et al.
Clinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents
JAMA, May 9, 2007; 297(18): 2001 - 2009.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M. C. John, H. K. Gold, and R. Virmani
Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization
Circulation, May 8, 2007; 115(18): 2435 - 2441.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
C. L. Grines, R. O. Bonow, D. E. Casey Jr, T. J. Gardner, P. B. Lockhart, D. J. Moliterno, P. O'Gara, and P. Whitlow
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians
J Am Dent Assoc, May 1, 2007; 138(5): 652 - 655.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. O. Maree and D. J. Fitzgerald
Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease
Circulation, April 24, 2007; 115(16): 2196 - 2207.
[Full Text] [PDF]


Home page
CirculationHome page
R. J. Gibbons
Leading the Elephant Out of the Corner: The Future of Health Care: Presidential Address at the American Heart Association 2006 Scientific Sessions
Circulation, April 24, 2007; 115(16): 2221 - 2230.
[Full Text] [PDF]


Home page
Eur Heart JHome page
B. J.G.L. de Smet and F. Zijlstra
A look at drug eluting stents with optical coherence tomography
Eur. Heart J., April 2, 2007; 28(8): 918 - 919.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. Eshaghian, S. Kaul, S. Amin, P. K. Shah, and G. A. Diamond
Role of Clopidogrel in Managing Atherothrombotic Cardiovascular Disease
Ann Intern Med, March 20, 2007; 146(6): 434 - 441.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Camenzind, P. G. Steg, and W. Wijns
A Cause for Concern
Circulation, March 20, 2007; 115(11): 1440 - 1455.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. L. Grines, R. O. Bonow, D. E. Casey Jr, T. J. Gardner, P. B. Lockhart, D. J. Moliterno, P. O'Gara, and P. Whitlow
Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents: A Science Advisory From the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, With Representation From the American College of Physicians
J. Am. Coll. Cardiol., February 13, 2007; 49(6): 734 - 739.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. L. Grines, R. O. Bonow, D. E. Casey Jr, T. J. Gardner, P. B. Lockhart, D. J. Moliterno, P. O'Gara, and P. Whitlow
Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents: A Science Advisory From the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, With Representation From the American College of Physicians
Circulation, February 13, 2007; 115(6): 813 - 818.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. J. Kereiakes
Does Clopidogrel Each Day Keep Stent Thrombosis Away?
JAMA, January 10, 2007; 297(2): 209 - 211.
[Full Text] [PDF]


Home page
JAMAHome page
E. L. Eisenstein, K. J. Anstrom, D. F. Kong, L. K. Shaw, R. H. Tuttle, D. B. Mark, J. M. Kramer, R. A. Harrington, D. B. Matchar, D. E. Kandzari, et al.
Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation
JAMA, January 10, 2007; 297(2): 159 - 168.
[Abstract] [Full Text] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
P. J. Geraghty
Bioabsorbable Stenting for Peripheral Arterial Occlusive Disease
Perspectives in Vascular Surgery and Endovascular Therapy, December 1, 2006; 18(4): 295 - 298.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
R. A. Harrington and R. M. Califf
Late Ischemic Events After Clopidogrel Cessation Following Drug-Eluting Stenting: Should We Be Worried?
J. Am. Coll. Cardiol., November 1, 2006; (2006) j.jacc.2006.10.025v2.
[Full Text] [PDF]


Home page
NEJMHome page
F. Van de Werf
Drug-Eluting Stents in Acute Myocardial Infarction
N. Engl. J. Med., September 14, 2006; 355(11): 1169 - 1170.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Profiling MI Patients with Drug-Eluting Stents Who Stop Thienopyridine Therapy
Journal Watch Cardiology, August 23, 2006; 2006(823): 4 - 4.
[Full Text]